Song Joon Ho, Lee Seoung Woo, Suh Chang-Kook, Kim Moon-Jae
Department of Internal Medicine, Inha University College of Medicine, Inchon City, Korea.
Am J Kidney Dis. 2002 Aug;40(2):291-301. doi: 10.1053/ajkd.2002.34507.
Factors determining sodium level during sodium-profiling hemodialysis rarely have been studied. We hypothesized that the time-averaged concentration of dialysate sodium (TAC(Na)) is related to intradialytic sodium load and interdialytic complications.
Eleven patients underwent 6-week periods of (1) conventional hemodialysis with a dialysate sodium concentration of 138 mmol/L (TAC(138)) and (2) sodium-profiling hemodialysis with a dialysate sodium concentration of 150 to 138 mmol/L (TAC(Na), 140 mmol/L [TAC(140)]) and (3) 155 to 130 mmol/L (TAC(Na), 147 mmol/L [TAC(147)]). Serum sodium level, weight gain, 24-hour blood pressure, and intradialytic and interdialytic discomfort were compared.
Serum sodium levels increased during the TAC(140) and TAC(147) periods (P < 0.05 compared with predialysis serum sodium). Intradialytic change in sodium level correlated positively with TAC(Na) (r = 0.945; P < 0.001). Regression analysis indicates that positive sodium load occurred with TAC(Na) more than 137.8 mmol/L. Interdialytic weight gain increased in proportion to TAC(Na) (P < 0.05 compared with each other period), with a positive correlation (r = 0.823; P < 0.001). TAC(Na) causing interdialytic weight gain less than 3 kg was estimated to be less than 143.5 mmol/L. Intradialytic hypotension decreased, but interdialytic discomforts increased during the TAC(147) period (P < 0.05 compared with TAC(138) and TAC(140)). Mean 24-hour blood pressures and pressure loads increased during the TAC(147) period (P < 0.05 compared with TAC(138) and TAC(140)). Mean diastolic blood pressure correlated positively with TAC(Na) (r = 0.354; P < 0.05).
TAC(Na) is a factor determining sodium load and interdialytic complications during sodium-profiling hemodialysis. Defining the optimal TAC(Na) for individual centers based on their protocols will be helpful to avoid sodium load and excessive weight gain.
很少有研究探讨钠曲线血液透析期间决定钠水平的因素。我们假设透析液钠的时间平均浓度(TAC(Na))与透析期间钠负荷及透析间期并发症有关。
11例患者分别接受为期6周的以下治疗:(1)采用138 mmol/L透析液钠浓度的常规血液透析(TAC(138));(2)采用150至138 mmol/L透析液钠浓度的钠曲线血液透析(TAC(Na),140 mmol/L [TAC(140)]);(3)采用155至130 mmol/L透析液钠浓度的钠曲线血液透析(TAC(Na),147 mmol/L [TAC(147)])。比较血清钠水平、体重增加、24小时血压以及透析期间和透析间期的不适情况。
在TAC(140)和TAC(147)期间血清钠水平升高(与透析前血清钠相比,P < 0.05)。透析期间钠水平的变化与TAC(Na)呈正相关(r = 0.945;P < 0.001)。回归分析表明,TAC(Na)超过137.8 mmol/L时会出现正钠负荷。透析间期体重增加与TAC(Na)成比例增加(与其他各期相比,P < 0.05),呈正相关(r = 0.823;P < 0.001)。导致透析间期体重增加少于3 kg的TAC(Na)估计低于143.5 mmol/L。透析期间低血压有所减少,但在TAC(147)期间透析间期不适增加(与TAC(138)和TAC(140)相比,P < 0.05)。在TAC(147)期间平均24小时血压和压力负荷增加(与TAC(138)和TAC(140)相比,P < 0.05)。平均舒张压与TAC(Na)呈正相关(r = 0.354;P < 0.05)。
TAC(Na)是钠曲线血液透析期间决定钠负荷及透析间期并发症的一个因素。根据各中心的方案确定最佳TAC(Na)将有助于避免钠负荷和体重过度增加。